New Treatment From Shockwave Medical For Clogged Arteries Gets CMS Pass-Through Payment
Executive Summary
Starting 1 July, Medicare beneficiaries with a certain type of cardiovascular disease will be able to receive an innovative treatment covered under their government plans.
You may also be interested in...
Shockwave Begins First All-Female Study Of Coronary Interventions
The EMPOWER CAD trial will evaluate Shockwave’s intravascular lithotripsy system in female patients undergoing a percutaneous coronary intervention for coronary artery disease. Principal investigator Alexandra Lansky spoke to Medtech Insight about the first-of-its kind study in this understudied population.
CMS Jolts Shockwave; Ups Payment For Coronary Artery Disease Treatment
The US Medicare agency increased payment for peripheral Intravascular Lithotripsy (IVL) procedures in a final rule. The increase is good news for Shockwave Medical, whose proprietary IVL treatment uses a novel approach to treating calcified arteries.
US Medicare Extends Add-On Payments For 13 Technologies
Citing the pandemic, the US Centers for Medicare & Medicaid Services (CMS) discounted 2020 data in reviewing renewals for New Technology Add-On Payment (NTAP) status and granted extensions through 30 September to 13 NTAP products.